nach oben

Erschienen in:

16.04.2019 | Vorhofflimmern | Fortbildung

Optimale Therapie bei Vorhofflimmern

Kryoablation

verfasst von: PD Dr. Kyoung-Ryul Julian Chun, Dr. Stefano Bordignon, PD Dr. Boris Schmidt

Erschienen in: CardioVasc | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Zusammenfassung

Die Katheterablation von Vorhofflimmern (VHF) repräsentiert das effektivste Verfahren zur erfolgreichen Rhythmuskontrolle und wird für therapierefraktäres paroxysmales VHF in den Leitlinien empfohlen. Die FIRE AND ICE-Studie konnte die Gleichwertigkeit des Kryoballons zur Radiofrequenz-Ablation für paroxysmales VHF nachweisen.

Kannel WB et al. Epidemiologic features of chronic atrial fibrillation: the Framingham study. N Engl J Med. 1982;306:1018–22CrossRef

Ostrander LD et al. Electrocardiographic findings among the adult population of a total natrural community, Tecumseh, Michigan. Circulation. 1965;31:888–98CrossRef

Kirchhof P et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;37:2893–962CrossRef

Piccini JP et al. Pulmonary vein isolation for the maintenance of sinus rhythm in patients with atrial fibrillation: a meta-analysis of randomized, controlled trials. Circ Arrhythm Electrophysiol. 2009;2:626–33CrossRef

Morillo CA et al. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation (RAAFT-2): a randomized trial. JAMA. 2014;311:692–700CrossRef

Calkins H et al. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Heart Rhythm. 2017;14:e275–e444CrossRef

Lin D et al. Electrophysiologic findings and long-term outcomes in patients undergoing third or more catheter ablation procedures for atrial fibrillation. J Cardiovasc Electrophysiol. 2015;26:371–7CrossRef

Chun KRJ, et al. The “single big cryoballoon” technique for acute pulmonary vein isolation in patients with paroxysmal atrial fibrillation: a prospective observational single centre study. Eur Heart J. 2009;30:699–709CrossRef

Chun KJ et al. Single transseptal big Cryoballoon pulmonary vein isolation using an inner lumen mapping catheter. Pacing Clin Electrophysiol PACE. 2012;35:1304–11CrossRef

10.

Heeger CH et al. Time-to-effect guided pulmonary vein isolation utilizing the third-generation versus second generation cryoballoon: One year clinical success. Cardiol J. 2018; https://doi.org/10.5603/CJ.a2018.00560

11.

Fürnkranz A et al. Procedural characteristics of pulmonary vein isolation using the novel third-generation cryoballoon. Eur Eur Pacing Arrhythm Card Electrophysiol J Work Groups Card Pacing Arrhythm Card Cell Electrophysiol Eur Soc Cardiol. 2016;18:1795–800

12.

Kuck KH et al. Cryoballoon or Radiofrequency Ablation for Paroxysmal Atrial Fibrillation. N Engl J Med. 2016;374:2235–45CrossRef

13.

Fürnkranz A et al. Improved procedural efficacy of pulmonary vein isolation using the novel second-generation cryoballoon. J Cardiovasc Electrophysiol. 2013;24:492–7CrossRef

14.

Providencia R et al. Results from a multicentre comparison of cryoballoon vs. radiofrequency ablation for paroxysmal atrial fibrillation: is cryoablation more reproducible? Eur Eur Pacing Arrhythm Card Electrophysiol J Work Groups Card Pacing Arrhythm Card Cell Electrophysiol Eur Soc Cardiol. 2017;19:48–57

15.

Bordignon S et al. High rate of durable pulmonary vein isolation after second-generation cryoballoon ablation: analysis of repeat procedures. Eur Eur Pacing Arrhythm Card Electrophysiol J Work Groups Card Pacing Arrhythm Card Cell Electrophysiol Eur Soc Cardiol. 2015;17:725–31

16.

Reddy VY et al. Durability of Pulmonary Vein Isolation with Cryoballoon Ablation: Results from the Sustained PV Isolation with Arctic Front Advance (SUPIR) Study. J Cardiovasc Electrophysiol. 2015;26:493–500CrossRef

17.

Koektuerk B et al. Cryoballoon Ablation for Pulmonary Vein Isolation in Patients With Persistent Atrial Fibrillation: One-Year Outcome Using Second Generation Cryoballoon. Circ Arrhythm Electrophysiol. 2015;8:1073–9CrossRef

18.

Boveda S et al. Single-Procedure Outcomes and Quality-of-Life Improvement 12 Months Post-Cryoballoon Ablation in Persistent Atrial Fibrillation: Results From the Multicenter CRYO4PERSISTENT AF Trial. JACC Clin Electrophysiol. 2018;4:1440–7CrossRef

19.

Schmidt B et al. Laser Balloon or Wide-Area Circumferential Irrigated Radiofrequency Ablation for Persistent Atrial Fibrillation: A Multicenter Prospective Randomized Study. Circ Arrhythm Electrophysiol 2017;10. https://doi.org/10.1161/CIRCEP.117.005767

20.

Bordignon S et al. Durable single shot cryoballoon isolation of the left atrial appendage followed by percutaneous left atrial appendage closure. Circ Arrhythm Electrophysiol. 2015;8:751–2CrossRef

21.

Yorgun H et al. Left atrial appendage isolation in addition to pulmonary vein isolation in persistent atrial fibrillation: one-year clinical outcome after cryoballoon-based ablation. Eur Eur Pacing Arrhythm Card Electrophysiol J Work Groups Card Pacing Arrhythm Card Cell Electrophysiol Eur Soc Cardiol. 2017;19:758–68

22.

Miyazaki S et al. Pulmonary Vein Isolation Using a Second-Generation Cryoballoon in Patients With Paroxysmal Atrial Fibrillation: One-Year Outcome Using a Single Big-Balloon 3-Minute Freeze Technique. J Cardiovasc Electrophysiol. 2016;27:1375–80CrossRef

23.

Ciconte G et al. Single 3-Minute versus Double 4-Minute Freeze Strategy for Second-Generation Cryoballoon Ablation: A Single-Center Experience. J Cardiovasc Electrophysiol. 2016;27:796–803CrossRef

24.

Chun KRJ et al. Individualized cryoballoon energy pulmonary vein isolation guided by real-time pulmonary vein recordings, the randomized ICE-T trial. Heart Rhythm. 2017;14:495–500CrossRef

25.

Dorwarth U et al. Pulmonary vein electrophysiology during cryoballoon ablation as a predictor for procedural success. J Interv Card Electrophysiol Int J Arrhythm Pacing. 2011;32:205–11CrossRef

26.

Aryana A et al. Procedural and biophysical indicators of durable pulmonary vein isolation during cryoballoon ablation of atrial fibrillation. Heart Rhythm. 2016;13:424–32CrossRef

27.

Cappato R et al. Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ Arrhythm Electrophysiol. 2010;3:32–8CrossRef

28.

Chun KRJ et al. Complications in Catheter Ablation of Atrial Fibrillation in 3,000 Consecutive Procedures: Balloon Versus Radiofrequency Current Ablation. JACC Clin Electrophysiol. 2017;3:154–61CrossRef

29.

Fürnkranz A et al. Reduced incidence of esophageal lesions by luminal esophageal temperature-guided second-generation cryoballoon ablation. Heart Rhythm. 2015;12:268–74CrossRef

30.

Ghosh J et al. Immediate balloon deflation for prevention of persistent phrenic nerve palsy during pulmonary vein isolation by balloon cryoablation. Heart Rhythm. 2013;10:646–52CrossRef

31.

Franceschi F et al. Diaphragmatic electromyography during cryoballoon ablation: a novel concept in the prevention of phrenic nerve palsy. Heart Rhythm. 2011;8:885–91CrossRef

32.

Nagase T et al. Low Risk of Pulmonary Vein Stenosis After Contemporary Atrial Fibrillation Ablation- Lessons From Repeat Procedures After Radiofrequency Current, Cryoballoon, and Laser Balloon. Circ J Off J Jpn Circ Soc. 2018;82:1558–65

Titel: Optimale Therapie bei Vorhofflimmern
Kryoablation
verfasst von: PD Dr. Kyoung-Ryul Julian Chun
Dr. Stefano Bordignon
PD Dr. Boris Schmidt
Publikationsdatum: 16.04.2019
Verlag: Springer Medizin
Schlagwörter: Vorhofflimmern
Ablationstherapie
Erschienen in: CardioVasc / Ausgabe 2/2019
Print ISSN: 1617-4933
Elektronische ISSN: 1618-3851
DOI: https://doi.org/10.1007/s15027-019-1541-1

Passend zum Thema

Leitlinien-Update und neue Pocket-Leitlinie vorgestellt von Prof. Möllmann

Vorhofflimmern

Die neue Leitlinie zur Behandlung von Herzklappenerkrankungen der European Society of Cardiology (ESC) und der European Association for Cardio-Thoracic Surgery (EACTS) ist ab jetzt als deutschsprachige Pocket-Leitlinien abrufbar. Die wichtigsten Neuerungen des Updates finden Sie hier von Prof. Dr. Helge Möllmann aus Dortmund für Sie zusammengefasst.

Expertenrat: Wer profitiert vom Vorhofohr-Verschluss

Vorhofflimmern

Der interventionelle Verschluss des linken Vorhofohrs ist eine in den Leitlinien empfohlene Alternative zur oralen Antikoagulation bei Menschen mit Vorhofflimmern. Bei welchen Patientinnen und Patienten Sie konkret an diese Alternative denken sollten – dazu gibt Kardiologe PD Dr. Zisis Dimitriadis alltagstaugliche Tipps.

Abbott Structural Heart

Content Hub

Wir helfen Menschen mit Strukturellen Herzerkrankungen ihre Lebensqualität zu verbessern. Entdecken Sie unser einzigartiges Produktportfolio für ihre Patienten.

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2019

Europäische myokardiale Revaskularisationsleitlinie 2018

Sportlerherz oder Kardiomyopathie? Zwei Parameter sind entscheidend

Inflammation als therapeutisches Target

ACC.19 is More Than a Meeting! ...

Radiofrequenz-Ablation

ARNI auch bei akut dekompensierter Herzinsuffizienz erfolgreich

Passend zum Thema

Leitlinien-Update und neue Pocket-Leitlinie vorgestellt von Prof. Möllmann

Expertenrat: Wer profitiert vom Vorhofohr-Verschluss

Abbott Structural Heart